The article examines the top 10 mid-cap healthcare stocks currently worth investing in. It discusses growth projections, challenges, and technological innovations in the global healthcare market.
Top 10 healthcare stocks with a mid-cap size to consider investing in. Read More »
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) had its target price raised by Cantor Fitzgerald analysts from $107.00 to $115.00 in a research report released on Friday.
Cantor Fitzgerald raises the price target for Ultragenyx Pharmaceutical to $115.00. Read More »
Read More: https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-insulet-podd-and-ultragenyx-pharmaceutical-rare?utm_source=alphanewsstream.com&utm_medium=referral
Analysts provide insights on healthcare companies Insulet and Ultragenyx Pharmaceutical. Read More »
Stay updated with the latests analysis and insights fromm etfsector.com